Ohio pharmacy board bans Hydroxychloroquine COVID-19 treatments across state

Ohio Board of Pharmacy says it's a patient safety issue, but the drug can still be used in controlled clinical trials
File photo
File photo(David J. Phillip | AP)
Updated: Jul. 29, 2020 at 8:26 PM EDT
Email This Link
Share on Pinterest
Share on LinkedIn

COLUMBUS, Ohio (WOIO) - Hydroxychloroquine will be prohibited as a treatment for COVID-19 in Ohio starting this Thursday, according to new regulations issued by the Ohio Board of Pharmacy.

Pharmacies and clinics will be banned from dispensing or selling the drug, which has been promoted by President Donald Trump as a potential treatment for the disease.

In a press conference this week, Trump said he took the drug in pill form for 14 days, and didn’t experience side effects.

However, a growing body of research conducted by the FDA and other major medical institutions points to heart rhythm risks.

The drug can still be used in clinical COVID-19 trials.

Copyright 2020 WOIO. All rights reserved.